Crowne Plaza London- The City
19 New Bridge Street
LONDON
EC4V 6DB
This conference will look at the latest in science, R&D, business strategies and legal issues for developing personalised therapeutics, and successfully introducing them to the marketplace. The conference will introduce both a pharmaceutical industry and a diagnostics industry perspective on the best way to move forward with developing companion diagnostics, marketing strategies, reimbursement issues and making personalised therapeutics viable in a commercial marketplace.
Questions considered during the conference will include: should pharma develop diagnostics internally, partner, or acquire diagnostic technologies? Is co-development the best method for companion diagnostics? What is the regulatory perspective on stratified and personalised therapeutics? How can the industry be creative with partnering strategies? Can current blockbuster drugs be repositioned as personalised medicines through resequencing? What are the public perception hurdles to be overcome? How do we identify and validate biomarkers for personalised medicines? How far can stem cell technologies be used to personalise therapeutics?
For further information please see the website:
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3448
